Literature DB >> 9306288

The neuropsychopharmacological potential of neuroactive steroids.

R Rupprecht1.   

Abstract

In addition to the well-known genomic effects of steroid molecules via intracellular steroid receptors, certain steroids rapidly alter neuronal excitability through interaction with neurotransmitter-gated ion channels. Several of these steroids accumulate in the brain after local synthesis or after metabolism of adrenal steroids. The 3 alpha-hydroxy ring A-reduced pregnane steroids allopregnanolone and tetrahydrodeoxycorticosterone have been thought not to interact with intracellular receptors but enhance 7-aminobutyric acid (GABA)-mediated chloride currents, whereas pregnenolone sulfate and dehydroepiandrosterone (DHEA) sulfate display functional antagonistic properties at GABAA receptors. We demonstrated that these neuroactive steroids can regulate also gene expression via the progesterone receptor after intracellular oxidation. Thus, in physiological concentrations these neuroactive steroids regulate neuronal function through their concurrent influence on transmitter-gated ion channels and gene expression. When administered in animal studies, memory enhancing effects have been shown for pregnenolone sulfate and DHEA. The 3 alpha-hydroxy ring A-reduced neuroactive steroids predominantly display anxiolytic, anticonvulsant and hypnotic activities. Sleep studies evaluating the effects of progesterone as a precursor molecule for these neuroactive steroids revealed a sleep EEG pattern similar to that obtained by the administration of benzodiazepines. These findings extend the concept of "cross-talk" between membrane and nuclear hormone effects and provide a new role for the therapeutic application of these steroids in neurology and psychiatry.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306288     DOI: 10.1016/s0022-3956(96)00060-x

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  20 in total

Review 1.  [New developments in pharmacotherapy of depression].

Authors:  R Rupprecht; Th C Baghai; H-J Möller
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

2.  Neurosteroids increase tonic GABAergic inhibition in the lateral section of the central amygdala in mice.

Authors:  H Romo-Parra; P Blaesse; L Sosulina; H-C Pape
Journal:  J Neurophysiol       Date:  2015-03-18       Impact factor: 2.714

3.  Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.

Authors:  Daniela Eser; Cornelius Schüle; Elena Romeo; Thomas C Baghai; Flavia di Michele; Augusto Pasini; Peter Zwanzger; Frank Padberg; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

Review 4.  Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.

Authors:  S N Seidman
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 5.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 6.  Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

Authors:  Michael S Ritsner
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

7.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

8.  Dysregulation of neurosteroids in obsessive compulsive disorder.

Authors:  K L Bigos; M M Folan; M R Jones; G L Haas; F J Kroboth; P D Kroboth
Journal:  J Psychiatr Res       Date:  2008-06-02       Impact factor: 4.791

Review 9.  Circadian rhythms in obsessive-compulsive disorder.

Authors:  Klaus W Lange; Katharina M Lange; Joachim Hauser; Lara Tucha; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2012-04-28       Impact factor: 3.575

10.  Anxiolytic-like Effect of Testosterone in Male Rats: GABAC Receptors Are Not Involved.

Authors:  Ali Roohbakhsh; Akbar Hajizadeh Moghaddam; Karim Mahmoodi Delfan
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.